Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8511-8520 Newer>

Pharmaceutical Executive January 1, 2013	Country Report: Singapore Most executives across the pharmaceutical industry agree; Singapore does not represent any question marks in the future. Furthermore, Singapore's location is ideal for reaching markets east, west, north and south, which form the powerhouse that is Asia-Pacific.
Pharmaceutical Executive January 1, 2013 Clark Herman	Who Lost Syria? Thankfully, the civil war is not a public relations issue for Big Pharma, but the long-term business implications for the Middle East region are cagey.
Pharmaceutical Executive January 1, 2013 Torsten Bernewitz	The Force Behind Sales Forces Don't underestimate the importance of the first line manager.
Pharmaceutical Executive January 1, 2013 Al Topin	The Doctor-Patient Disconnect Doctor-patient conversations aren't always what we think; this basic interaction represents both a problem and an opportunity for today's drug marketers, says the author.
Pharmaceutical Executive January 1, 2013 Jill Wechsler	Transformation to Characterize 2013 FDA policies will reshape drug development, while pressure to cut healthcare spending may alter drug coverage and pricing.
Pharmaceutical Executive January 1, 2013 William Looney	The Long Swim -- Upstream As we near the midway point in the "tween" decade, there is good fortune in store for those in the pharmaceutical industry with the perspective that comes with the long view.
Chemistry World January 22, 2013 Andrew Turley	Flu vaccine without the eggs approved Flublok from US biotech Protein Sciences has become the first flu vaccine made using an insect virus to win marketing approval in the US.
Chemistry World January 21, 2013 Andy Extance	India pushes for emergency drug licenses The Indian government is preparing to grant compulsory licenses allowing three patented cancer drugs to be produced in the country and sold at reduced rates without permission from the patent owners.
Chemistry World January 21, 2013 Michael Parkin	Flow synthesis for anticancer drug UK chemists have used a combination of flow chemistry methods with solid-supported scavengers and reagents to synthesize the active pharmaceutical ingredient, imatinib, of the anticancer drug Gleevec.
Chemistry World January 16, 2013 Andrew Turley	BASF ups Pronova bid BASF has increased its offer for Norwegian firm Pronova BioPharma, which specializes in omega-3 fatty acids, from 664 million euro to 684 million euro in an attempt to win over reluctant shareholders.
<Older 8511-8520 Newer> Return to current articles.